![Leesa Gentry](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leesa Gentry
Chief Tech/Sci/R&D Officer at
RENOVORX, INC.
Net worth: - $ as of 2026-05-30
Profile
Ms. Leesa Gentry is a Chief Clinical Officer at RenovoRx, Inc. Ms. Gentry was previously employed as a Senior Vice President-Clinical Operations by Evotec AG.
She also served on the board at Otsuka Pharmaceutical Development & Commercialization, Inc. She received her undergraduate degree from the University of Central Missouri, a graduate degree from the University of Central Missouri and a graduate degree from the University of Mary Hardin-Baylor.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RENOVORX, INC. -.--% | 2026-04-14 | 0 ( -.--% ) | - $ | 2026-05-30 |
Leesa Gentry active positions
| Companies | Position | Start |
|---|---|---|
| RENOVORX, INC. | Chief Tech/Sci/R&D Officer | 2023-04-24 |
Former positions of Leesa Gentry
| Companies | Position | End |
|---|---|---|
| EVOTEC SE | Corporate Officer/Principal | 2018-11-30 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Comptroller/Controller/Auditor | 2018-11-30 |
Training of Leesa Gentry
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
33
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
RenovoRx, Inc.
 RenovoRx, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops therapies for the local treatment of solid tumors | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
University of Central Missouri
 University of Central Missouri Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mary Hardin-Baylor
 University of Mary Hardin-Baylor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Leesa Gentry
